Searchline. Let us do the hunting whatever expert you need. Please call our free SearchLine today on 0161 834 0017

Search Results Detail back to results

Dr Adnan Sharif

Professional Description:

Consultant Nephrologist

Qualifications:

MD FRCP MBChB

Address:
Queen Elizabeth Hospital Birmingham
Mindelsohn Way
Edgbaston
Birmingham
B15 2WB
Area of work:

Midlands & Nationwide

Details

Dr Adnan Sharif is a Consultant Nephrologist at the Queen Elizabeth Hospital Birmingham and Honorary Reader at the University of Birmimngham.

He graduated from the University of Edinburgh in 2002 and underwent his medical and nephrology training in Cardiff and Birmingham respectively, before starting his Consultant post in 2011.

He retains an active research focus and is currently Chief Investigator on a number of prospective cohort and randomized clinical trials related to dialysis and kidney transplantation. In addition to his clinical and research interests, he is the secretary of the non-Government Organization Doctors Against Forced Organ Harvesting (DAFOH) which campaigns against illegal and unethical organ procurement around the globe and the group was nominated for the 2016 Nobel Peace Prize for its work in this area.

He also sits on the steering committee for Give A Kidney, a registered charity that promotes non-directed altruistic kidney donation and is a member of the National BAME Transplantation Alliance that seeks to promote blood, stem cell and organ donation from minority ethnic groups in the UK.

Dr Sharif is an expert speaker on the Advanced Nephrology course since 2017; topic ‘Malignancy and PTLD after kidney transplantation’. Also for the European Society of Organ Transplantation education course; topic ‘Infectious considerations post-transplant’.

He is heavily involved in research and areas include:
• Chief Investigator: Comparing Glycaemic Benefits of Active Versus Passive Lifestyle Intervention in Kidney Allograft Recipients (CAVIAR) - NCT02233491
• Chief Investigator: AGe-adapted benefits of Envarsus versus twice-daily tacrolimus ImmunosuppressioN druGs after kidney transplantation (AGEING) – a feasibility study - NCT03005236
• Chief Investigator: Frailty Intervention Trial in End-Stage Patients on Dialysis (FITNESS) - NCT03071107
• Chief Investigator: Epidemiology of Cancer After Solid Organ Transplantation (EpCOT) - NCT02991105
• Post-Transplantation Diabetes Mellitus
• Black, Asian and Minority Ethnic issues relating to organ donation and transplantation
• Antibody-incompatible transplantation
• Transplantation ethics

Membership

Renal Association, International Society of Nephrology, Medical Protection Society, British Transplantation Society, European Renal Association-European Dialysis and Transplant Association, European Society for Organ Transplantation, Royal College of Physicians (Edinburgh)

back to results